
Formistar G 2mg/500mg Tablet ER
Marketer
Iva Healthcare Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Formistar G 2mg/500mg Tablet ER
Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose in diabetic patients. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function assessments) are recommended by your doctor.
Primary Ingredients of Formistar G 2mg/500mg Tablet ER
The provided text is "undefined," which cannot be rephrased. There is no text to rewrite.
Uses of Formistar G 2mg/500mg Tablet ER
Managing Type 2 diabetes
Major Benefits of Formistar G 2mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Formistar G 2mg/500mg Extended-Release Tablet with food.
Common Side effects of Formistar G 2mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Formistar G 2mg/500mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Formistar G 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Formistar G 2mg/500mg Tablet ER works:
Formistar G 2mg/500mg Extended-Release tablets combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Formistar G 2mg/500mg Extended-Release Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Formistar G 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Extended-release Formistar G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Formistar G 2mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Formistar G 2mg/500mg Extended-Release tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Formistar G 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation with a reduced Formistar G 2mg/500mg ER dosage is typical; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Formistar G 2mg/500mg Tablet ER :
Should you forget a dose of Formistar G 2mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Formistar G 2mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
